Metagenomic next generation sequencing for the diagnosis of tuberculosis meningitis: A systematic review and meta-analysis
- PMID: 33259541
- PMCID: PMC7707562
- DOI: 10.1371/journal.pone.0243161
Metagenomic next generation sequencing for the diagnosis of tuberculosis meningitis: A systematic review and meta-analysis
Abstract
Background: Tuberculous meningitis (TBM) is a severe form of extrapulmonary tuberculosis and its early diagnosis is very difficult leading to present with severe disability or die. The current study aimed to assess the accuracy of metagenomic next generation sequencing (mNGS) for TBM, and to identify a new test for the early diagnosis of TBM.
Methods: We searched for articles published in Embase, PubMed, Cochrane Library, China National Knowledge Infrastructure, and Wanfang Data up to June 30, 2020 for studies that assessed the efficacy of mNGS for the diagnosis of TBM. Then, the accuracy between mNGS and a composite reference standard (CRS) in these articles was compared using the meta-analysis approach.
Results: Four independent studies with 342 samples comparing mNGS and a CRS were included in this study. The sensitivity of mNGS for TBM diagnosis ranged from 27% to 84%. The combined sensitivity of mNGS was 61%, and the I2 value was 92%. Moreover, the specificity of mNGS for TBM diagnosis ranged from 96% to 100%. The combined specificity of mNGS was 98%, and the I2 value was 74%. The heterogeneity between studies in terms of sensitivity and specificity was significant. The area under the curve (AUC) of the summary receiver operating characteristic curve (SROC) of mNGS for TBM was 0.98.
Conclusions: The sensitivity of mNGS for TBM diagnosis was moderate. Furthermore, the specificity was extremely high, and the AUC of the SROC indicated a very good diagnostic efficacy. mNGS could be used as an early diagnostic method for TBM, however, the results should be treated with caution for the heterogeneity between studies was extremely significant.
Systematic review registration: INPLASY202070100.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Comparison of the efficacy of metagenomic next-generation sequencing and Xpert MTB/RIF in the diagnosis of tuberculous meningitis.J Microbiol Methods. 2021 Jan;180:106124. doi: 10.1016/j.mimet.2020.106124. Epub 2020 Dec 13. J Microbiol Methods. 2021. PMID: 33321144
-
Metagenomic Next-Generation Sequencing (mNGS) in cerebrospinal fluid for rapid diagnosis of Tuberculosis meningitis in HIV-negative population.Int J Infect Dis. 2020 Jul;96:270-275. doi: 10.1016/j.ijid.2020.04.048. Epub 2020 Apr 24. Int J Infect Dis. 2020. PMID: 32339718
-
Clinical efficacy of metagenomic next-generation sequencing for rapid detection of Mycobacterium tuberculosis in smear-negative extrapulmonary specimens in a high tuberculosis burden area.Int J Infect Dis. 2021 Feb;103:91-96. doi: 10.1016/j.ijid.2020.11.165. Epub 2020 Nov 20. Int J Infect Dis. 2021. PMID: 33227518
-
A systematic review and meta-analysis of the diagnostic accuracy of metagenomic next-generation sequencing for diagnosing tuberculous meningitis.Front Immunol. 2023 Sep 26;14:1223675. doi: 10.3389/fimmu.2023.1223675. eCollection 2023. Front Immunol. 2023. PMID: 37822937 Free PMC article.
-
Diagnostic accuracy of the metagenomic next-generation sequencing (mNGS) for detection of bacterial meningoencephalitis: a systematic review and meta-analysis.Eur J Clin Microbiol Infect Dis. 2022 Jun;41(6):881-891. doi: 10.1007/s10096-022-04445-0. Epub 2022 Apr 26. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35474146
Cited by
-
Determination of Ideal Factors for Early Adoption and Standardization of Metagenomic Next-generation Sequencing for Respiratory System Infections.Curr Pharm Biotechnol. 2024;25(17):2266-2277. doi: 10.2174/0113892010246350231030042340. Curr Pharm Biotechnol. 2024. PMID: 38347797
-
Application of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in patients with lower respiratory tract infections.J Int Med Res. 2022 Apr;50(4):3000605221089795. doi: 10.1177/03000605221089795. J Int Med Res. 2022. PMID: 35481370 Free PMC article.
-
Application of metagenomic next-generation sequencing in cutaneous tuberculosis.Front Cell Infect Microbiol. 2022 Sep 23;12:942073. doi: 10.3389/fcimb.2022.942073. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36211955 Free PMC article.
-
The importance of antimicrobial resistance in medical mycology.Nat Commun. 2022 Sep 12;13(1):5352. doi: 10.1038/s41467-022-32249-5. Nat Commun. 2022. PMID: 36097014 Free PMC article. Review.
-
Clinical Value of Metagenomic Next-Generation Sequencing Using Spinal Tissue in the Rapid Diagnosis of Spinal Tuberculosis.Infect Drug Resist. 2023 May 29;16:3305-3313. doi: 10.2147/IDR.S410914. eCollection 2023. Infect Drug Resist. 2023. PMID: 37274359 Free PMC article.
References
-
- World Health Organization. Global tuberculosis report 2019. Geneva, Switzerland; 2019.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources